Clinical trial · Observational
Bio Clinical Collection of Urothelial Carcinoma
NCT04970472CI-TRIAL-00106042MicroBladrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to collect tumor samples, urines, stool and blood from patients with urothelial carcinoma. These samples will be stored in a secure and confidential laboratory of the Toulouse University Hospital.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Urothelial Carcinoma | Urothelial Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| collection of blood, urines, stool and tumor samples | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- patients with Urothelial bladder carcinoma
- description
- collection of blood, urines, stool and tumor samples
- interventionNames
- Biological: collection of blood, urines, stool and tumor samples
Primary outcomes (2)
- measure
- Collection and long-term collection of blood, urines, stool and tumor samples from patients with Urothelial bladder carcinoma for future biological and/or surrogate marker studies.
- timeFrame
- Day 0
- description
- Transcriptomic analysis
- measure
- Collection and long-term collection of blood, urines, stool and tumor samples from patients with Urothelial bladder carcinoma for future biological and/or surrogate marker studies.
- timeFrame
- during the intervention/procedure/surgery
- description
- Transcriptomic, proteomic and epigenetic analysis
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * Adult \>18 years old * Patient with suspected or diagnosed Urothelial carcinoma * Patients who are willing to consent for this protocol. Exclusion Criteria: * Pregnant or breastfeeding patients * Patients under 18 years old * Patients under guardianship or curators * Patients unable to sign a free and informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.